Board Meeting21 May 2026, 06:01 pm
Bafna Pharma Board Meeting on May 29, 2026 for Audited Results
AI Summary
Bafna Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026. The trading window for designated persons remains closed from April 1, 2026, to May 31, 2026.
Key Highlights
- Board meeting scheduled for May 29, 2026 to approve audited financial results.
- Results are for the quarter and year ended March 31, 2026.
- Trading window closed from April 1 to May 31, 2026.
Price Impact
More from BAFNAPHARM